Senegal vs Togo: Cause of death, by non-communicable diseases, ages 5-14, male
Senegal
22.3%
in 2021
Togo
22.7%
in 2021
Senegal rank
139th
Togo rank
137th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Senegal
- Togo
How they compare
Togo currently reports 22.7% against 22.3% in Senegal, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Togo ahead.
Senegal ranks 139th and Togo ranks 137th of 185 countries.
Across the 3 decades both report, Senegal averaged higher in 1 and Togo in 2.
Head to head by decade
| Decade | Senegal | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.2% | 15.7% | 0.5% | Togo |
| 2010s | 21.7% | 19.8% | 1.9% | Senegal |
| 2020s | 22.3% | 22.8% | 0.5% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Senegal or Togo?
- Togo, at 22.7% against 22.3% in Senegal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Senegal and Togo?
- 0.4%, with Togo ahead.
- How many years of comparable data are there for Senegal and Togo?
- 6 years are reported by both, from 2000 to 2021.
- How do Senegal and Togo rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Senegal ranks 139th and Togo ranks 137th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.